Location History:
- Biberach, DE (2012)
- Biberach an der Riss, DE (2014 - 2024)
Company Filing History:
Years Active: 2012-2025
Title: The Innovative Contributions of Marc Grundl
Introduction
Marc Grundl is a prominent inventor based in Biberach an der Riss, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cGAS inhibitors. With a total of 19 patents to his name, Grundl's work is recognized for its potential impact on medical science.
Latest Patents
Among his latest patents are innovative compounds such as pyridine derivatives with n-linked cyclic substituents and pyridine derivatives with c-linked cyclic substituents, both designed as cGAS inhibitors. These inventions relate to new proline derivatives that hold promise for therapeutic applications.
Career Highlights
Marc Grundl is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role involves extensive research and development, focusing on creating novel therapeutic agents that can address unmet medical needs.
Collaborations
Throughout his career, Grundl has collaborated with notable colleagues, including Alexander Pautsch and Matthias Grauert. These partnerships have fostered a collaborative environment that enhances innovation and accelerates the development of new therapies.
Conclusion
Marc Grundl's contributions to the field of pharmaceuticals through his innovative patents and collaborative efforts highlight his importance as an inventor. His work continues to pave the way for advancements in medical science.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.